<DOC>
	<DOCNO>NCT02645682</DOCNO>
	<brief_summary>The purpose study investigate effect anti-infective central venous catheter ( Certofix®Protect ) reduce catheter-related bloodstream infection critically ill patient China , relationship catheter-related bloodstream infection catheter-related thrombosis .</brief_summary>
	<brief_title>The Effects Anti-infective Central Venous Catheter Catheter-related Infection Critically Patients</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Catheter-Related Infections</mesh_term>
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>adult patient intensive care unit ( ICU ) （age ≥ 18 years） need double lumen CVC 5 day Signed informed consent thrombosis target and/or contralateral vein pregnancy lactate woman unlikely survive 1 month bad prognosis suspect catheterrelated infection replacement CVC original site guide wire severe burn situation suitable CVC , include allergic CVC material , thrombosis target vein , infection puncture site , coagulation disorder , abnormal anatomy already study participated study within 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>central venous catheter ( CVC )</keyword>
	<keyword>catheter-related bloodstream infection ( CRBSI )</keyword>
	<keyword>catheter-related thrombosis ( CRT )</keyword>
</DOC>